APO Research
Talk to an analyst

APO RESEARCH · REPORT

Codeine Phosphate Compound Oral Solution

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Codeine Phosphate Compound Oral Solution Market Outlook and Growth Opportunities 2026

27 December 2025191 pages

Choose your research edition.

Industry ResearchCodeine Phosphate Compound Oral Solution Industry Research Report 2026109 pages · $2,950 USDIndustry Growth & TrendsGlobal Codeine Phosphate Compound Oral Solution Industry Growth and Trends Forecast to 203275 pages · $3,450 USDMarket StructureGlobal Codeine Phosphate Compound Oral Solution Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032172 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Codeine Phosphate Compound Oral Solution Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Codeine Phosphate Compound Oral Solution Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Codeine Phosphate Compound Oral Solution market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Codeine Phosphate Compound Oral Solution is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Codeine Phosphate Compound Oral Solution is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Codeine Phosphate Compound Oral Solution is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Codeine Phosphate Compound Oral Solution market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Codeine Phosphate Compound Oral Solution market include Bright Future Pharmaceuticals Factory, Shiyao Group Zhongnuo Pharmaceutic, Shandong Xinhua Pharmaceutical and Tianjin Lisheng Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Codeine Phosphate Compound Oral Solution market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Codeine Phosphate Compound Oral Solution and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Codeine Phosphate Compound Oral Solution sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Codeine Phosphate Compound Oral Solution market size, projected growth trends, production technologies, key applications, and end-use industries.

Codeine Phosphate Compound Oral Solution Segment by Company

Bright Future Pharmaceuticals Factory

Shiyao Group Zhongnuo Pharmaceutic

Shandong Xinhua Pharmaceutical

Tianjin Lisheng Pharmaceutical

Codeine Phosphate Compound Oral Solution Segment by Type

150ml

100ml

Codeine Phosphate Compound Oral Solution Segment by Application

Hospital

Clinic

Others

Codeine Phosphate Compound Oral Solution Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Codeine Phosphate Compound Oral Solution status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Codeine Phosphate Compound Oral Solution market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Codeine Phosphate Compound Oral Solution significant trends, drivers, influence factors in global and regions.

6. To analyze Codeine Phosphate Compound Oral Solution competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Codeine Phosphate Compound Oral Solution market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Codeine Phosphate Compound Oral Solution and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Codeine Phosphate Compound Oral Solution.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Codeine Phosphate Compound Oral Solution market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Codeine Phosphate Compound Oral Solution industry.

Chapter 3: Detailed analysis of Codeine Phosphate Compound Oral Solution manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Codeine Phosphate Compound Oral Solution in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Codeine Phosphate Compound Oral Solution in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Codeine Phosphate Compound Oral Solution Industry Trends Table 2. Codeine Phosphate Compound Oral Solution Industry Drivers Table 3. Codeine Phosphate Compound Oral Solution Industry Opportunities and Challenges Table 4. Codeine Phosphate Compound Oral Solution Industry Restraints Table 5. Global Codeine Phosphate Compound Oral Solution Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Codeine Phosphate Compound Oral Solution Revenue Share by Company (2021-2026) Table 7. Global Codeine Phosphate Compound Oral Solution Sales Volume by Company (L) & (2021-2026) Table 8. Global Codeine Phosphate Compound Oral Solution Sales Volume Share by Company (2021-2026) Table 9. Global Codeine Phosphate Compound Oral Solution Average Price (US$/L) of Company (2021-2026) Table 10. Global Codeine Phosphate Compound Oral Solution Company Ranking, (2024-2026) & (USD Million) Table 11. Global Codeine Phosphate Compound Oral Solution Key Company Manufacturing Base & Headquarters Table 12. Global Codeine Phosphate Compound Oral Solution Company, Product Type & Application Table 13. Global Codeine Phosphate Compound Oral Solution Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Codeine Phosphate Compound Oral Solution by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of 150ml Table 18. Significant Companies of 100ml Table 19. Global Codeine Phosphate Compound Oral Solution Sales Volume by Type 2021 VS 2025 VS 2032 (L) Table 20. Global Codeine Phosphate Compound Oral Solution Sales Volume by Type (2021-2026) & (L) Table 21. Global Codeine Phosphate Compound Oral Solution Sales Volume by Type (2027-2032) & (L) Table 22. Global Codeine Phosphate Compound Oral Solution Sales Volume Share by Type (2021-2026) Table 23. Global Codeine Phosphate Compound Oral Solution Sales Volume Share by Type (2027-2032) Table 24. Global Codeine Phosphate Compound Oral Solution Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Codeine Phosphate Compound Oral Solution Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Codeine Phosphate Compound Oral Solution Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Codeine Phosphate Compound Oral Solution Sales Value Share by Type (2021-2026) Table 28. Global Codeine Phosphate Compound Oral Solution Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Hospital Table 30. Significant Companies of Clinic Table 31. Significant Companies of Others Table 32. Global Codeine Phosphate Compound Oral Solution Sales Volume by Application 2021 VS 2025 VS 2032 (L) Table 33. Global Codeine Phosphate Compound Oral Solution Sales Volume by Application (2021-2026) & (L) Table 34. Global Codeine Phosphate Compound Oral Solution Sales Volume by Application (2027-2032) & (L) Table 35. Global Codeine Phosphate Compound Oral Solution Sales Volume Share by Application (2021-2026) Table 36. Global Codeine Phosphate Compound Oral Solution Sales Volume Share by Application (2027-2032) Table 37. Global Codeine Phosphate Compound Oral Solution Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Codeine Phosphate Compound Oral Solution Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Codeine Phosphate Compound Oral Solution Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Codeine Phosphate Compound Oral Solution Sales Value Share by Application (2021-2026) Table 41. Global Codeine Phosphate Compound Oral Solution Sales Value Share by Application (2027-2032) Table 42. Global Codeine Phosphate Compound Oral Solution Sales by Region: 2021 VS 2025 VS 2032 (L) Table 43. Global Codeine Phosphate Compound Oral Solution Sales by Region (2021-2026) & (L) Table 44. Global Codeine Phosphate Compound Oral Solution Sales Market Share by Region (2021-2026) Table 45. Global Codeine Phosphate Compound Oral Solution Sales by Region (2027-2032) & (L) Table 46. Global Codeine Phosphate Compound Oral Solution Sales Market Share by Region (2027-2032) Table 47. Global Codeine Phosphate Compound Oral Solution Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Codeine Phosphate Compound Oral Solution Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Codeine Phosphate Compound Oral Solution Sales Value Share by Region (2021-2026) Table 50. Global Codeine Phosphate Compound Oral Solution Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Codeine Phosphate Compound Oral Solution Sales Value Share by Region (2027-2032) Table 52. Global Codeine Phosphate Compound Oral Solution Market Average Price (US$/L) by Region (2021-2026) Table 53. Global Codeine Phosphate Compound Oral Solution Market Average Price (US$/L) by Region (2027-2032) Table 54. Global Codeine Phosphate Compound Oral Solution Sales by Country: 2021 VS 2025 VS 2032 (L) Table 55. Global Codeine Phosphate Compound Oral Solution Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Codeine Phosphate Compound Oral Solution Sales by Country (2021-2026) & (L) Table 57. Global Codeine Phosphate Compound Oral Solution Sales Market Share by Country (2021-2026) Table 58. Global Codeine Phosphate Compound Oral Solution Sales by Country (2027-2032) & (L) Table 59. Global Codeine Phosphate Compound Oral Solution Sales Market Share by Country (2027-2032) Table 60. Global Codeine Phosphate Compound Oral Solution Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Codeine Phosphate Compound Oral Solution Sales Value Market Share by Country (2021-2026) Table 62. Global Codeine Phosphate Compound Oral Solution Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Codeine Phosphate Compound Oral Solution Sales Value Market Share by Country (2027-2032) Table 64. Bright Future Pharmaceuticals Factory Company Information Table 65. Bright Future Pharmaceuticals Factory Business Overview Table 66. Bright Future Pharmaceuticals Factory Codeine Phosphate Compound Oral Solution Sales (L), Value (US$ Million), Price (US$/L) and Gross Margin (2021-2026) Table 67. Bright Future Pharmaceuticals Factory Codeine Phosphate Compound Oral Solution Product Portfolio Table 68. Bright Future Pharmaceuticals Factory Recent Development Table 69. Shiyao Group Zhongnuo Pharmaceutic Company Information Table 70. Shiyao Group Zhongnuo Pharmaceutic Business Overview Table 71. Shiyao Group Zhongnuo Pharmaceutic Codeine Phosphate Compound Oral Solution Sales (L), Value (US$ Million), Price (US$/L) and Gross Margin (2021-2026) Table 72. Shiyao Group Zhongnuo Pharmaceutic Codeine Phosphate Compound Oral Solution Product Portfolio Table 73. Shiyao Group Zhongnuo Pharmaceutic Recent Development Table 74. Shandong Xinhua Pharmaceutical Company Information Table 75. Shandong Xinhua Pharmaceutical Business Overview Table 76. Shandong Xinhua Pharmaceutical Codeine Phosphate Compound Oral Solution Sales (L), Value (US$ Million), Price (US$/L) and Gross Margin (2021-2026) Table 77. Shandong Xinhua Pharmaceutical Codeine Phosphate Compound Oral Solution Product Portfolio Table 78. Shandong Xinhua Pharmaceutical Recent Development Table 79. Tianjin Lisheng Pharmaceutical Company Information Table 80. Tianjin Lisheng Pharmaceutical Business Overview Table 81. Tianjin Lisheng Pharmaceutical Codeine Phosphate Compound Oral Solution Sales (L), Value (US$ Million), Price (US$/L) and Gross Margin (2021-2026) Table 82. Tianjin Lisheng Pharmaceutical Codeine Phosphate Compound Oral Solution Product Portfolio Table 83. Tianjin Lisheng Pharmaceutical Recent Development Table 84. Key Raw Materials Table 85. Raw Materials Key Suppliers Table 86. Codeine Phosphate Compound Oral Solution Distributors List Table 87. Codeine Phosphate Compound Oral Solution Customers List Table 88. Research Programs/Design for This Report Table 89. Authors List of This Report Table 90. Secondary Sources Table 91. Primary Sources List of Figures Figure 1. Codeine Phosphate Compound Oral Solution Product Image Figure 2. Global Codeine Phosphate Compound Oral Solution Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Codeine Phosphate Compound Oral Solution Sales Value (2021-2032) & (US$ Million) Figure 4. Global Codeine Phosphate Compound Oral Solution Sales (2021-2032) & (L) Figure 5. Global Codeine Phosphate Compound Oral Solution Sales Average Price (US$/L) & (2021-2032) Figure 6. Global Codeine Phosphate Compound Oral Solution Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. 150ml Image Figure 10. 100ml Image Figure 11. Global Codeine Phosphate Compound Oral Solution Sales Volume by Type (2021 VS 2025 VS 2032) & (L) Figure 12. Global Codeine Phosphate Compound Oral Solution Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Codeine Phosphate Compound Oral Solution Sales Volume Share by Type (2021-2032) Figure 14. Global Codeine Phosphate Compound Oral Solution Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Codeine Phosphate Compound Oral Solution Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Codeine Phosphate Compound Oral Solution Sales Value Share by Type (2021-2032) Figure 17. Hospital Image Figure 18. Clinic Image Figure 19. Others Image Figure 20. Global Codeine Phosphate Compound Oral Solution Sales Volume by Application (2021 VS 2025 VS 2032) & (L) Figure 21. Global Codeine Phosphate Compound Oral Solution Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Codeine Phosphate Compound Oral Solution Sales Volume Share by Application (2021-2032) Figure 23. Global Codeine Phosphate Compound Oral Solution Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Codeine Phosphate Compound Oral Solution Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Codeine Phosphate Compound Oral Solution Sales Value Share by Application (2021-2032) Figure 26. Global Codeine Phosphate Compound Oral Solution Sales by Region: 2021 VS 2025 VS 2032 (L) Figure 27. Global Codeine Phosphate Compound Oral Solution Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Codeine Phosphate Compound Oral Solution Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Codeine Phosphate Compound Oral Solution Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Codeine Phosphate Compound Oral Solution Sales Value (2021-2032) & (US$ Million) Figure 31. North America Codeine Phosphate Compound Oral Solution Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Codeine Phosphate Compound Oral Solution Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Codeine Phosphate Compound Oral Solution Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Codeine Phosphate Compound Oral Solution Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Codeine Phosphate Compound Oral Solution Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Codeine Phosphate Compound Oral Solution Sales Value (2021-2032) & (US$ Million) Figure 37. South America Codeine Phosphate Compound Oral Solution Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Codeine Phosphate Compound Oral Solution Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Codeine Phosphate Compound Oral Solution Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Codeine Phosphate Compound Oral Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Codeine Phosphate Compound Oral Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Codeine Phosphate Compound Oral Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Codeine Phosphate Compound Oral Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Codeine Phosphate Compound Oral Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Codeine Phosphate Compound Oral Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Codeine Phosphate Compound Oral Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Codeine Phosphate Compound Oral Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Codeine Phosphate Compound Oral Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Codeine Phosphate Compound Oral Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Codeine Phosphate Compound Oral Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Codeine Phosphate Compound Oral Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Codeine Phosphate Compound Oral Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Codeine Phosphate Compound Oral Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Codeine Phosphate Compound Oral Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Codeine Phosphate Compound Oral Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Codeine Phosphate Compound Oral Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Codeine Phosphate Compound Oral Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Codeine Phosphate Compound Oral Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Codeine Phosphate Compound Oral Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Codeine Phosphate Compound Oral Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Codeine Phosphate Compound Oral Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Codeine Phosphate Compound Oral Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Codeine Phosphate Compound Oral Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Codeine Phosphate Compound Oral Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Codeine Phosphate Compound Oral Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Codeine Phosphate Compound Oral Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Codeine Phosphate Compound Oral Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Codeine Phosphate Compound Oral Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Codeine Phosphate Compound Oral Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Codeine Phosphate Compound Oral Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Codeine Phosphate Compound Oral Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Codeine Phosphate Compound Oral Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Codeine Phosphate Compound Oral Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Codeine Phosphate Compound Oral Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Codeine Phosphate Compound Oral Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Codeine Phosphate Compound Oral Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Codeine Phosphate Compound Oral Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Codeine Phosphate Compound Oral Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Codeine Phosphate Compound Oral Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Codeine Phosphate Compound Oral Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Codeine Phosphate Compound Oral Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Codeine Phosphate Compound Oral Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Codeine Phosphate Compound Oral Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Codeine Phosphate Compound Oral Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Codeine Phosphate Compound Oral Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Codeine Phosphate Compound Oral Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Codeine Phosphate Compound Oral Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Codeine Phosphate Compound Oral Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Codeine Phosphate Compound Oral Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Codeine Phosphate Compound Oral Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Codeine Phosphate Compound Oral Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Codeine Phosphate Compound Oral Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Codeine Phosphate Compound Oral Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Codeine Phosphate Compound Oral Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Codeine Phosphate Compound Oral Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Codeine Phosphate Compound Oral Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Codeine Phosphate Compound Oral Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Codeine Phosphate Compound Oral Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Codeine Phosphate Compound Oral Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Codeine Phosphate Compound Oral Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Codeine Phosphate Compound Oral Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Codeine Phosphate Compound Oral Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Codeine Phosphate Compound Oral Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Codeine Phosphate Compound Oral Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Codeine Phosphate Compound Oral Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Codeine Phosphate Compound Oral Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Codeine Phosphate Compound Oral Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Codeine Phosphate Compound Oral Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Codeine Phosphate Compound Oral Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Codeine Phosphate Compound Oral Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Codeine Phosphate Compound Oral Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Codeine Phosphate Compound Oral Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Codeine Phosphate Compound Oral Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Codeine Phosphate Compound Oral Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Codeine Phosphate Compound Oral Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Codeine Phosphate Compound Oral Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Codeine Phosphate Compound Oral Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Codeine Phosphate Compound Oral Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Codeine Phosphate Compound Oral Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Codeine Phosphate Compound Oral Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Codeine Phosphate Compound Oral Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Codeine Phosphate Compound Oral Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Codeine Phosphate Compound Oral Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Codeine Phosphate Compound Oral Solution Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Codeine Phosphate Compound Oral Solution Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • 150ml
  • 100ml
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • Bright Future Pharmaceuticals Factory
  • Shiyao Group Zhongnuo Pharmaceutic
  • Shandong Xinhua Pharmaceutical
  • Tianjin Lisheng Pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Codeine Phosphate Compound Oral Solution Sales Value (2021-2032)
  4. 1.2.2 Global Codeine Phosphate Compound Oral Solution Sales Volume (2021-2032)
  5. 1.2.3 Global Codeine Phosphate Compound Oral Solution Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Codeine Phosphate Compound Oral Solution Market Dynamics
  1. 2.1 Codeine Phosphate Compound Oral Solution Industry Trends
  2. 2.2 Codeine Phosphate Compound Oral Solution Industry Drivers
  3. 2.3 Codeine Phosphate Compound Oral Solution Industry Opportunities and Challenges
  4. 2.4 Codeine Phosphate Compound Oral Solution Industry Restraints
3 Codeine Phosphate Compound Oral Solution Market by Company
  1. 3.1 Global Codeine Phosphate Compound Oral Solution Company Revenue Ranking in 2025
  2. 3.2 Global Codeine Phosphate Compound Oral Solution Revenue by Company (2021-2026)
  3. 3.3 Global Codeine Phosphate Compound Oral Solution Sales Volume by Company (2021-2026)
  4. 3.4 Global Codeine Phosphate Compound Oral Solution Average Price by Company (2021-2026)
  5. 3.5 Global Codeine Phosphate Compound Oral Solution Company Ranking (2024-2026)
  6. 3.6 Global Codeine Phosphate Compound Oral Solution Company Manufacturing Base and Headquarters
  7. 3.7 Global Codeine Phosphate Compound Oral Solution Company Product Type and Application
  8. 3.8 Global Codeine Phosphate Compound Oral Solution Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Codeine Phosphate Compound Oral Solution Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Codeine Phosphate Compound Oral Solution Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Codeine Phosphate Compound Oral Solution Market by Type
  1. 4.1 Codeine Phosphate Compound Oral Solution Type Introduction
  2. 4.1.1 150ml
  3. 4.1.2 100ml
  4. 4.2 Global Codeine Phosphate Compound Oral Solution Sales Volume by Type
  5. 4.2.1 Global Codeine Phosphate Compound Oral Solution Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Codeine Phosphate Compound Oral Solution Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Codeine Phosphate Compound Oral Solution Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Codeine Phosphate Compound Oral Solution Sales Value by Type
  9. 4.3.1 Global Codeine Phosphate Compound Oral Solution Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Codeine Phosphate Compound Oral Solution Sales Value by Type (2021-2032)
  11. 4.3.3 Global Codeine Phosphate Compound Oral Solution Sales Value Share by Type (2021-2032)
5 Codeine Phosphate Compound Oral Solution Market by Application
  1. 5.1 Codeine Phosphate Compound Oral Solution Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Others
  5. 5.2 Global Codeine Phosphate Compound Oral Solution Sales Volume by Application
  6. 5.2.1 Global Codeine Phosphate Compound Oral Solution Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Codeine Phosphate Compound Oral Solution Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Codeine Phosphate Compound Oral Solution Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Codeine Phosphate Compound Oral Solution Sales Value by Application
  10. 5.3.1 Global Codeine Phosphate Compound Oral Solution Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Codeine Phosphate Compound Oral Solution Sales Value by Application (2021-2032)
  12. 5.3.3 Global Codeine Phosphate Compound Oral Solution Sales Value Share by Application (2021-2032)
6 Codeine Phosphate Compound Oral Solution Regional Sales and Value Analysis
  1. 6.1 Global Codeine Phosphate Compound Oral Solution Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Codeine Phosphate Compound Oral Solution Sales by Region (2021-2032)
  3. 6.2.1 Global Codeine Phosphate Compound Oral Solution Sales by Region: 2021-2026
  4. 6.2.2 Global Codeine Phosphate Compound Oral Solution Sales by Region (2027-2032)
  5. 6.3 Global Codeine Phosphate Compound Oral Solution Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Codeine Phosphate Compound Oral Solution Sales Value by Region (2021-2032)
  7. 6.4.1 Global Codeine Phosphate Compound Oral Solution Sales Value by Region: 2021-2026
  8. 6.4.2 Global Codeine Phosphate Compound Oral Solution Sales Value by Region (2027-2032)
  9. 6.5 Global Codeine Phosphate Compound Oral Solution Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Codeine Phosphate Compound Oral Solution Sales Value (2021-2032)
  12. 6.6.2 North America Codeine Phosphate Compound Oral Solution Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Codeine Phosphate Compound Oral Solution Sales Value (2021-2032)
  15. 6.7.2 Europe Codeine Phosphate Compound Oral Solution Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Codeine Phosphate Compound Oral Solution Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Codeine Phosphate Compound Oral Solution Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Codeine Phosphate Compound Oral Solution Sales Value (2021-2032)
  21. 6.9.2 South America Codeine Phosphate Compound Oral Solution Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Codeine Phosphate Compound Oral Solution Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Codeine Phosphate Compound Oral Solution Sales Value Share by Country, 2025 VS 2032
7 Codeine Phosphate Compound Oral Solution Country-level Sales and Value Analysis
  1. 7.1 Global Codeine Phosphate Compound Oral Solution Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Codeine Phosphate Compound Oral Solution Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Codeine Phosphate Compound Oral Solution Sales by Country (2021-2032)
  4. 7.3.1 Global Codeine Phosphate Compound Oral Solution Sales by Country (2021-2026)
  5. 7.3.2 Global Codeine Phosphate Compound Oral Solution Sales by Country (2027-2032)
  6. 7.4 Global Codeine Phosphate Compound Oral Solution Sales Value by Country (2021-2032)
  7. 7.4.1 Global Codeine Phosphate Compound Oral Solution Sales Value by Country (2021-2026)
  8. 7.4.2 Global Codeine Phosphate Compound Oral Solution Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Codeine Phosphate Compound Oral Solution Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Codeine Phosphate Compound Oral Solution Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Codeine Phosphate Compound Oral Solution Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Codeine Phosphate Compound Oral Solution Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Codeine Phosphate Compound Oral Solution Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Codeine Phosphate Compound Oral Solution Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Codeine Phosphate Compound Oral Solution Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Codeine Phosphate Compound Oral Solution Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Codeine Phosphate Compound Oral Solution Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Codeine Phosphate Compound Oral Solution Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Codeine Phosphate Compound Oral Solution Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Codeine Phosphate Compound Oral Solution Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Codeine Phosphate Compound Oral Solution Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Codeine Phosphate Compound Oral Solution Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Codeine Phosphate Compound Oral Solution Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Codeine Phosphate Compound Oral Solution Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Codeine Phosphate Compound Oral Solution Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Codeine Phosphate Compound Oral Solution Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Codeine Phosphate Compound Oral Solution Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Codeine Phosphate Compound Oral Solution Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Codeine Phosphate Compound Oral Solution Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Codeine Phosphate Compound Oral Solution Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Codeine Phosphate Compound Oral Solution Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Codeine Phosphate Compound Oral Solution Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Codeine Phosphate Compound Oral Solution Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Codeine Phosphate Compound Oral Solution Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Codeine Phosphate Compound Oral Solution Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Codeine Phosphate Compound Oral Solution Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Codeine Phosphate Compound Oral Solution Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Codeine Phosphate Compound Oral Solution Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Codeine Phosphate Compound Oral Solution Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Codeine Phosphate Compound Oral Solution Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Codeine Phosphate Compound Oral Solution Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Codeine Phosphate Compound Oral Solution Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Codeine Phosphate Compound Oral Solution Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Codeine Phosphate Compound Oral Solution Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Codeine Phosphate Compound Oral Solution Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Codeine Phosphate Compound Oral Solution Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Codeine Phosphate Compound Oral Solution Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Codeine Phosphate Compound Oral Solution Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Codeine Phosphate Compound Oral Solution Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Codeine Phosphate Compound Oral Solution Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Codeine Phosphate Compound Oral Solution Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Codeine Phosphate Compound Oral Solution Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Codeine Phosphate Compound Oral Solution Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Codeine Phosphate Compound Oral Solution Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Codeine Phosphate Compound Oral Solution Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Codeine Phosphate Compound Oral Solution Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Codeine Phosphate Compound Oral Solution Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Codeine Phosphate Compound Oral Solution Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Codeine Phosphate Compound Oral Solution Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Codeine Phosphate Compound Oral Solution Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Codeine Phosphate Compound Oral Solution Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Codeine Phosphate Compound Oral Solution Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Codeine Phosphate Compound Oral Solution Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Codeine Phosphate Compound Oral Solution Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Codeine Phosphate Compound Oral Solution Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Codeine Phosphate Compound Oral Solution Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Codeine Phosphate Compound Oral Solution Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Codeine Phosphate Compound Oral Solution Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Codeine Phosphate Compound Oral Solution Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Codeine Phosphate Compound Oral Solution Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Codeine Phosphate Compound Oral Solution Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Codeine Phosphate Compound Oral Solution Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Codeine Phosphate Compound Oral Solution Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Codeine Phosphate Compound Oral Solution Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Codeine Phosphate Compound Oral Solution Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Codeine Phosphate Compound Oral Solution Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Codeine Phosphate Compound Oral Solution Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Codeine Phosphate Compound Oral Solution Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Codeine Phosphate Compound Oral Solution Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Codeine Phosphate Compound Oral Solution Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Codeine Phosphate Compound Oral Solution Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Codeine Phosphate Compound Oral Solution Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Codeine Phosphate Compound Oral Solution Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Codeine Phosphate Compound Oral Solution Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Codeine Phosphate Compound Oral Solution Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Codeine Phosphate Compound Oral Solution Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Codeine Phosphate Compound Oral Solution Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Codeine Phosphate Compound Oral Solution Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Codeine Phosphate Compound Oral Solution Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Codeine Phosphate Compound Oral Solution Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Codeine Phosphate Compound Oral Solution Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Codeine Phosphate Compound Oral Solution Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Bright Future Pharmaceuticals Factory
  2. 8.1.1 Bright Future Pharmaceuticals Factory Company Information
  3. 8.1.2 Bright Future Pharmaceuticals Factory Business Overview
  4. 8.1.3 Bright Future Pharmaceuticals Factory Codeine Phosphate Compound Oral Solution Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Bright Future Pharmaceuticals Factory Codeine Phosphate Compound Oral Solution Product Portfolio
  6. 8.1.5 Bright Future Pharmaceuticals Factory Recent Developments
  7. 8.2 Shiyao Group Zhongnuo Pharmaceutic
  8. 8.2.1 Shiyao Group Zhongnuo Pharmaceutic Company Information
  9. 8.2.2 Shiyao Group Zhongnuo Pharmaceutic Business Overview
  10. 8.2.3 Shiyao Group Zhongnuo Pharmaceutic Codeine Phosphate Compound Oral Solution Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Shiyao Group Zhongnuo Pharmaceutic Codeine Phosphate Compound Oral Solution Product Portfolio
  12. 8.2.5 Shiyao Group Zhongnuo Pharmaceutic Recent Developments
  13. 8.3 Shandong Xinhua Pharmaceutical
  14. 8.3.1 Shandong Xinhua Pharmaceutical Company Information
  15. 8.3.2 Shandong Xinhua Pharmaceutical Business Overview
  16. 8.3.3 Shandong Xinhua Pharmaceutical Codeine Phosphate Compound Oral Solution Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Shandong Xinhua Pharmaceutical Codeine Phosphate Compound Oral Solution Product Portfolio
  18. 8.3.5 Shandong Xinhua Pharmaceutical Recent Developments
  19. 8.4 Tianjin Lisheng Pharmaceutical
  20. 8.4.1 Tianjin Lisheng Pharmaceutical Company Information
  21. 8.4.2 Tianjin Lisheng Pharmaceutical Business Overview
  22. 8.4.3 Tianjin Lisheng Pharmaceutical Codeine Phosphate Compound Oral Solution Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Tianjin Lisheng Pharmaceutical Codeine Phosphate Compound Oral Solution Product Portfolio
  24. 8.4.5 Tianjin Lisheng Pharmaceutical Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Codeine Phosphate Compound Oral Solution Value Chain Analysis
  2. 9.1.1 Codeine Phosphate Compound Oral Solution Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Codeine Phosphate Compound Oral Solution Sales Mode & Process
  6. 9.2 Codeine Phosphate Compound Oral Solution Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Codeine Phosphate Compound Oral Solution Distributors
  9. 9.2.3 Codeine Phosphate Compound Oral Solution Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst